# Eagle Nuclear Energy Corp.: financial statements, quarterly

NUCL · Nasdaq · CIK 2089283 · [Materials](/sectors/materials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/nucl.md) · [Financials](/companies/nucl/financials.md) · [Filings](/companies/nucl/filings.md) · [Insiders](/companies/nucl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nucl/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(0.7)](/filings/0001104659-26-043856.md) | [(1.0)](/filings/0001104659-26-085069.md) | [(1.3)](/filings/0001104659-26-115550.md) | [(1.5)](/filings/0001104659-26-043856.md) | [(25.1)](/filings/0001104659-26-085069.md) | [4.3](/filings/0001104659-26-115550.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001104659-26-043856.md) | [(0.06)](/filings/0001104659-26-085069.md) | not reported | [(0.08)](/filings/0001104659-26-043856.md) | [(0.87)](/filings/0001104659-26-085069.md) | not reported |
| Basic EPS | $ per share | [(0.04)](/filings/0001104659-26-043856.md) | [(0.06)](/filings/0001104659-26-085069.md) | not reported | [(0.08)](/filings/0001104659-26-043856.md) | [(0.87)](/filings/0001104659-26-085069.md) | not reported |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | period not labelled (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [1.3](/filings/0001104659-26-043856.md) | [4.9](/filings/0001104659-26-085069.md) | [3.4](/filings/0001104659-26-115550.md) | [1.3](/filings/0001104659-26-115550.md) | [31.3](/filings/0001104659-26-043856.md) | [28.1](/filings/0001104659-26-085069.md) | [25.5](/filings/0001104659-26-115550.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [1.5](/filings/0001104659-26-115550.md) | [31.5](/filings/0001104659-26-043856.md) | [29.0](/filings/0001104659-26-085069.md) | [26.2](/filings/0001104659-26-115550.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [2.9](/filings/0001104659-26-115550.md) | [45.6](/filings/0001104659-26-043856.md) | [43.1](/filings/0001104659-26-085069.md) | [40.3](/filings/0001104659-26-115550.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [0.8](/filings/0001104659-26-115550.md) | [0.8](/filings/0001104659-26-043856.md) | [1.8](/filings/0001104659-26-085069.md) | [1.3](/filings/0001104659-26-115550.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [0.9](/filings/0001104659-26-115550.md) | [5.6](/filings/0001104659-26-043856.md) | [24.3](/filings/0001104659-26-085069.md) | [15.7](/filings/0001104659-26-115550.md) |
| Shareholders' equity | $m | [(0.6)](/filings/0001104659-26-115550.md) | [1.1](/filings/0001104659-26-085069.md) | [5.3](/filings/0001104659-26-115550.md) | [4.0](/filings/0001104659-26-115550.md) | [1.7](/filings/0001104659-26-115550.md) | [14.4](/filings/0001104659-26-085069.md) | [(7.0)](/filings/0001104659-26-115550.md) | [(2.3)](/filings/0001104659-26-115550.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(786)](/filings/0001104659-26-043856.md) | [(1,158) d](/filings/0001104659-26-085069.md) | [(1,514) d](/filings/0001104659-26-115550.md) | [(1,569)](/filings/0001104659-26-043856.md) | [(3,143) d](/filings/0001104659-26-085069.md) | [(2,629) d](/filings/0001104659-26-115550.md) |
| Capital expenditure | $k | not reported | not reported | not reported | [43.1](/filings/0001104659-26-043856.md) | [4.9 d](/filings/0001104659-26-085069.md) | [6.9 d](/filings/0001104659-26-115550.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-02-28) | period not labelled (2025-05-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.8](/filings/0001104659-26-043856.md) | [17.7](/filings/0001104659-26-085069.md) | [19.4](/filings/0001104659-26-043856.md) | [29.7](/filings/0001104659-26-085069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,683,966 at 2026-10-09, from the cover of the [10-Q filed 2026-10-13](/filings/0001104659-26-115550.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.